A personalized testing service using patient-derived organoids to evaluate drug efficacy and identify optimal therapeutic candidates for individual cancer treatment protocols.
Manufactured by
China
Accurate International Biotechnology is an innovative biotech company with organoid technology as its core focus, serving personalized medicine, drug development, and regenerative medicine. As the Guangdong Provincial Organoid Engineering Technology Research Center, the company is ISO13485 certified with headquarters in Guangzhou and R&D centers in Beijing, Shanghai, Macau, and Milan. The company operates a comprehensive organoid technology platform covering reagents, biomaterials, automated equipment, chips, and AI databases.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
NOROVA
China · 4 relevant products
Beijing Diagreat Biotechnologies Co., Ltd
China · 1 relevant product
Jiangsu Avatarget Biotechnology Limited Liability Company
China · 2 relevant products
AcroCyte Therapeutics, Inc.
Taiwan · 1 relevant product
Biopsense Oy
Finland · 1 relevant product
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 1 relevant product
in.vent Diagnostica GmbH
Germany · 1 relevant product
Biofortuna Limited
United Kingdom · 1 relevant product
LifeOS Genomics Corporation
Taiwan · 1 relevant product
STEVANATO GROUP
China · 1 relevant product
14 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →1 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 38 closest product alternatives
NOROVA · China
Scientific research service providing tumor organoid development and analysis for research institutions and clinical centers. Supports preclinical and translational oncology research. Facilitates drug efficacy testing and personalized treatment validation.
NOROVA · China
Personalized precision medicine service for malignant tumors using organoid technology. Enables accurate diagnosis and treatment planning through patient-derived tumor models. Supports clinical decision-making for oncology patients.
NOROVA · China
A research service platform leveraging organoid technology with advantages of rapid growth cycles, easy experimental operation, and convenient high-throughput screening. Organoids serve as powerful diagnostic tools and research platforms for clinical and scientific applications in cancer research.
Beijing Diagreat Biotechnologies Co., Ltd · China
Comprehensive genetic testing service supporting precision drug therapy and personalized medicine applications. Integrates molecular analysis with therapeutic drug monitoring for comprehensive patient profiling.
Jiangsu Avatarget Biotechnology Limited Liability Company · China
Comprehensive pharmaceutical development service utilizing organ chip platforms for preclinical efficacy and toxicity assessment. Covers early discovery through clinical trial preparation phases.
AcroCyte Therapeutics, Inc. · Taiwan
A clinical service that provides personalized treatment planning using patient-derived 3D cell culture models. The service leverages cultured patient cells to enable precision medicine approaches in cancer care. It supports clinicians in making informed treatment decisions based on individual patient cell behavior.
NOROVA · China
A research service leveraging organoid technology as a powerful diagnostic tool and research platform due to its fast growth cycle, ease of experimental operation, and convenient high-throughput screening capabilities. Organoids are three-dimensional in vitro cultured tissue analogues formed from adult stem cells or pluripotent stem cells, featuring high morphological and genetic similarity to corresponding human organ tissues and the ability to recapitulate organ physiological functions.
Biopsense Oy · Finland
Comprehensive diagnostic service utilizing liquid biopsy technology for cancer detection, monitoring, and treatment response evaluation. Supports oncologists in selecting optimal cancer medications and detecting drug resistance through frequent, non-invasive blood sampling.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Comprehensive precision medicine solutions covering over 2000 service items across oncology, maternal-child health, cardiovascular, and infectious diseases. Services include disease screening, early diagnosis, molecular profiling, drug sensitivity selection, efficacy monitoring, and prognosis assessment.
in.vent Diagnostica GmbH · Germany
Professional assay development and optimization services for diagnostic test development.
Biofortuna Limited · United Kingdom
Custom development of diagnostic assays including molecular and immunoassay formats. Supports innovation in diagnostic test creation from concept through optimization.
LifeOS Genomics Corporation · Taiwan
Co-development service enabling laboratories to create custom assay panels using their proprietary biomarkers combined with LifeOS mdPCR tagging technology. Provides competitive advantage in sensitivity and multiplexity for specialized diagnostic applications.
26 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products